Corcept Therapeutics Incorporated
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Corcept Therapeutics Incorporated
Rona hopes technology acquired from Sanofi will enhance its RNA capabilities in liver and non-liver indications. NeuroFront gets Greater China and Singapore rights to Novaremed’s neuropathic pain drug.
National Resilience, Parker Institute team to incubate cancer startups. Metropolitan AntiViral Drug Accelerator will focus on eight molecular features of SARS-CoV-2 to create novel oral antivirals.
Value-added medicines firm Hyloris has raised €15m from new and existing investors through a private equity offering of nearly one million new shares.
Robotic-assisted surgery is moving into a different phase of growth. New competitors with new ideas are coming into the industry and user awareness has been enhanced. UK scale-up CMR Surgical views these as healthy developments, says business development chief Bertrand Weil.
- Other Names / Subsidiaries
- Corcept Therapeutics Inc.